Gunther Schmidt

USPTO Granted Patents = 12 (Patent Applications = 4)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 1)

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 52(Granted Patents)

Location History:

Basel, CH (2014)
Allschwil, CH (2015 - 2021)
Aarau, CH (2009 - 2023)

Company Filing History:

5 out of 14

Philera New Zealand Limited

patents

4 out of 217

Actelion Pharmaceuticals Ltd

Protemix Corporation Limited

patents

5. 1 out of 77

Idorsia Pharmaceuticals Ltd

patents

Years Active: 2009-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11795150 - Synthesis of triethylenetetramines (2023-10-24),

2. 11124488 - Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives (2021-09-21),

3. 9556123 - Synthesis of triethylenetetramines (2017-01-31),

4. 9187476 - Process for manufacturing naphthyridine derivatives (2015-11-17),

5. 9127002 - Process for manufacturing a naphthyridine derivative (2015-09-08),

6. 8912362 - Synthesis of triethylenetetramines (2014-12-16),

7. 8912340 - Process for the preparation of 2-imino-thiazolidin-4-one derivatives (2014-12-16),

8. 8394992 - Synthesis of triethylenetetramines (2013-03-12),

9. 8338621 - Process for the preparation of 2-oxo-1-pyrrolidine derivatives (2012-12-25),

10. 8263780 - Process for the preparation of 2-imino-thiazolidin-4-one derivatives (2012-09-11),

11. 8067641 - Synthesis of triethylenetetramines (2011-11-29),

12. 7582796 - Synthesis of triethylenetetramines (2009-09-01),

Title: Gunther Schmidt: Innovator in Chemical Synthesis

Introduction

Gunther Schmidt is a notable inventor based in Aarau, Switzerland. He has made significant contributions to the field of chemical synthesis, holding a total of 12 patents. His work focuses on innovative methods and compounds that have applications in pharmaceuticals and other industries.

Latest Patents

Among his latest patents, Schmidt has developed methods for the synthesis of triethylenetetramines. This includes the creation of novel triethylenetetramine salts and their crystal structures. Additionally, he has worked on the preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives, which are crucial for the development of various pharmaceuticals.

Career Highlights

Throughout his career, Gunther Schmidt has been associated with prominent companies such as Philera New Zealand Limited and Actelion Pharmaceuticals Ltd. His expertise in chemical synthesis has allowed him to contribute to groundbreaking research and development projects.

Collaborations

Schmidt has collaborated with several professionals in his field, including Marco Jonas and Irene Vaulont. These partnerships have enhanced his research and expanded the impact of his inventions.

Conclusion

Gunther Schmidt's innovative work in chemical synthesis and his numerous patents highlight his significant role in advancing pharmaceutical research. His contributions continue to influence the industry and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.